A method for drug concentration detection based on surface enhanced Raman spectroscopy
By optimizing the SERS detection method through ultrasonic incubation of the sample pretreatment solution with the SERS probe and calculation of the characteristic peak area, the problems of inhomogeneity and repeatability in drug concentration detection were solved, and highly sensitive and repeatable quantitative drug detection was achieved.
Patent Information
- Application Number
- CN202410426493.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-10
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-04-10
AI Technical Summary
Existing SERS colloidal nanoprobe techniques for detecting drug concentration suffer from system inhomogeneity and reproducibility issues, and common improvement methods are either costly or have a narrow detection range.
By mixing the sample pretreatment solution with the SERS probe and incubating it with ultrasound, combined with the calculation of characteristic peak area, the data acquisition scheme was optimized to improve the repeatability and sensitivity of the detection.
It achieves stable detection of a variety of drugs with high sensitivity and repeatability, significantly improving detection repeatability and sensitivity, and is suitable for quantitative detection of drugs such as methotrexate and voriconazole.
Smart Images

Figure CN118329862B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of surface enhanced Raman spectroscopy (SERS) detection technology, and in particular to a method for improving the repeatability of analog signal SERS technology to detect drugs such as methotrexate and voriconazole. Background Art
[0002] In the existing application of many drugs, it is necessary to frequently monitor drug concentrations, especially low-concentration detection. For example, methotrexate is a drug that requires frequent low-concentration detection. Methotrexate (Methotrexate, referred to as "MTX") is a commonly used anti-tumor drug. It inhibits the growth and spread of tumor cells by inhibiting cell proliferation and immune response, blocking the synthesis and repair of DNA and RNA. High-dose methotrexate (HDMTX) therapy is to increase the dose of methotrexate to more than 5 times the conventional treatment dose, which is used to treat certain malignant tumors such as leukemia, but due to its large toxic and side effects, the dosage and cycle of the drug need to be strictly controlled under the guidance of a doctor. The "Guidelines for Evidence-Based Use of High-Dose Methotrexate in China" recommends routine implementation of therapeutic drug monitoring (Therapeutic Drug Monitoring, referred to as "TDM") (end of infusion, 24h, 48h, 72h). Among them, the toxic concentration of MTX: 24h administration>4μg / mL, 48h administration>0.4μg / mL, 72h administration>0.04μg / mL; the concentration of MTX with less adverse reactions: 24h administration<2μg / mL, 48h administration<0.2μg / mL. When delayed elimination, acute kidney injury or other serious adverse events occur, the monitoring interval should be shortened and the monitoring frequency should be increased. In current clinical applications, the methods for quantitative detection of methotrexate are mass spectrometry, high performance liquid chromatography, or a combination of the two. The equipment and consumables involved in these methods are expensive, and the detection time required is long. Therefore, it is necessary to develop a simple and low-cost method to achieve rapid quantitative detection of drugs such as MTX with a wide linear range and high sensitivity.
[0003] Surface enhanced Raman spectroscopy (SERS) is a spectral technique based on the Raman scattering effect. It uses the surface enhancement effect of solid substrates or colloidal nanoprobes to increase the Raman signal intensity of molecules, thereby enhancing the sensitivity and resolution of the spectrum. Due to its non-destructive, rapid and highly sensitive advantages, SERS is often used to analyze trace samples and has a wide range of applications in the fields of analysis and biomedical research. Among them, SERS colloidal nanoprobes are large in batches, low in cost and have good uniformity, and are particularly suitable for drug concentration monitoring. In the SERS colloidal nanoprobe detection system, the SERS signal intensity and repeatability of the target molecule are mainly affected by the following points: the electric field on the SERS probe surface; the number of molecules adsorbed or very close to the probe surface and the Raman scattering cross section of the molecule; and the optical system conditions. This is related to factors such as experimental conditions, sample preparation, measuring instruments, and data processing. In order to obtain higher detection sensitivity and expand the detection limit of analog signal SERS technology, developers often use agglomerators to aggregate SERS probes to introduce more hot spots. However, inappropriate aggregation is bound to lead to system inhomogeneity, thereby introducing additional repeatability issues.
[0004] The main problems with the existing SERS colloidal nanoprobe technology for detecting drug concentration are:
[0005] 1. When agglomerating agents are used to improve detection sensitivity, the system becomes inhomogeneous, introducing detection repeatability issues.
[0006] 2. Currently, the most common method to improve SERS repeatability is the calibration method using internal standard Raman signal molecules. The SERS colloidal nanoprobes used in this method are generally core-shell nanostructures with embedded Raman signal molecules or nanostructures with surface modified Raman signal molecules. The former has a complex preparation method and high cost, while the latter can adsorb a small number of target molecules and has a narrow detection range.
[0007] 3. In the detection of analog signal SERS technology, there is no relevant standard for the number of SERS spectra collected, resulting in the lack of representativeness of the collected spectra. Summary of the invention
[0008] In order to solve the problems existing in the above-mentioned technologies, the present invention provides a SERS detection method without internal standard calibration which can improve repeatability and is used for the quantitative detection of drugs such as methotrexate.
[0009] The present invention provides a method for drug concentration detection based on surface enhanced Raman spectroscopy, which comprises the following steps:
[0010] Step 1: Mix the sample pretreatment solution with the sample in a certain proportion to obtain a pretreated sample, wherein the sample pretreatment solution is one or more of sodium salt, potassium salt, calcium salt, and magnesium salt;
[0011] Step 2: While sonicating the SERS probe, quickly add the pre-treated sample for mixed incubation;
[0012] Step 3: Perform SERS detection on the incubated sample after ultrasonication to obtain original spectral data;
[0013] Step 4: Select the characteristic peak of the target detection object, calculate its peak area in the average spectrum as the signal, draw a standard curve, and realize quantitative detection.
[0014] Preferably, in step S2, the volume ratio of the added pre-treated sample to the SERS probe is 1:3 to 3:1.
[0015] Preferably, the concentration of the sample pretreatment solution ranges from 0.01 to 150 mM.
[0016] Preferably, the SERS probe comprises any one of silver, gold and platinum, and its particle size is 20 to 200 nm.
[0017] Preferably, the ultrasound is water bath ultrasound, and the ultrasound power is 200-1000 Hz.
[0018] Preferably, the SERS spectra of the samples are collected in scanning mode, and the number of spectra collected for each sample is not less than Zhang, where σ is the standard deviation, E is the acceptable sampling error, and Z α / 2 is the reliability coefficient.
[0019] Preferably, when the confidence level is 95% and the acceptable relative sampling error is 10%, the specific number of spectra collected is not less than y=6.747x -0.705 +8, where x is the concentration of the substance to be tested, and y is the minimum number of spectra collected to test samples near this concentration;
[0020] The characteristic peak area is calculated as the peak center wave number ±5 to 30 cm after removing the baseline. -1 The integrated area within the range.
[0021] Preferably, the sample is methotrexate, voriconazole or verapamil hydrochloride.
[0022] Preferably, the steps of the SERS probe for detecting MTX (methotrexate) samples are:
[0023] Prepare pretreatment solution: an aqueous solution containing 135-145 mM NaCl, 3.5-5 mM KCl, 2.2-2.6 mM CaCl2, and 0.7-1 mM MgCl2;
[0024] Sample pretreatment: Mix 10 μL MTX sample with 90 μL pretreatment solution for subsequent testing;
[0025] Place the incubation tube containing the SERS nanoprobe in an ultrasonic bath, turn on the ultrasound, and quickly add the pre-treated sample at a volume ratio of 1:3 to 3:1. Continue ultrasound for 10 seconds and incubate at 20°C in the dark for 10 minutes.
[0026] Detection: Ultrasonicate the incubated samples for 10 seconds and take an appropriate amount of sample for detection.
[0027] Preferably, the preparation process of the SERS probe is as follows:
[0028] Add 110 mL of ultrapure water to a three-necked flask, place it in an oil bath, turn on magnetic stirring, and set the stirring speed to 800 rpm;
[0029] Weigh 23 mg of AgNO3 in 40 mL of ultrapure water and vortex to mix. Add 40 mL of AgNO3 aqueous solution into a three-necked flask, mix well, and protect from light;
[0030] Turn on heat and bring to boil;
[0031] Weigh 40 mg of sodium citrate solution in 4 mL of ultrapure water and vortex to mix; add 2 mL of sodium citrate solution into the three-necked flask at a uniform rate within 5 minutes;
[0032] After boiling for 1 hour, stop heating; place the three-necked flask at room temperature away from light, and continue stirring for 3 hours until it cools down.
[0033] The prepared sodium citrate silver nano-SERS probe was stored at 2-8°C in the dark.
[0034] The beneficial effects of the present invention are:
[0035] (1) The method of the present invention for detecting multiple drugs based on surface enhanced Raman spectroscopy technology can achieve high sensitivity, high repeatability and stable detection of multiple drugs through sample pretreatment, incubation, SERS detection, data processing and other steps. In addition to methotrexate detection, the present invention also verifies again that the optimization scheme has the effect of significantly improving repeatability by detecting voriconazole and verapamil hydrochloride. In addition, the present invention investigates the short-term stability of the optimized detection system and proves that its detection is stable.
[0036] (2) Pre-treat the sample, i.e., prepare and add a pre-treatment solution. The pre-treatment solution acts as an agglomeration agent for the SERS nanoprobe. The addition of the agglomeration agent will form more hot spots. When the target molecule approaches or adsorbs on the hot spot, its Raman signal will be greatly enhanced, thereby improving the detection sensitivity and even achieving single molecule detection.
[0037] In order to ensure the reliability of quantitative detection, when using SERS nanoprobe aggregates for detection, it is necessary to pay attention to the balance between the degree of aggregation and the degree of uniformity. This is not only related to the SERS nanoprobe itself and the agglomeration agent, but also involves the addition and mixing methods of the sample, agglomeration agent and SERS nanoprobe.
[0038] Generally speaking, there are two addition orders: one is to first add the aggregating agent to the nanoprobe to promote its aggregation, and then add the sample to be tested for detection; the other is to first mix the sample and the nanoprobe evenly, then add the aggregating agent to make it aggregate, and then detect. In the former case, the nanoprobe aggregates first, but it takes a certain time for it to reach stability, which will extend the overall detection time; if the sample is added when it is not stable, the aggregates in the system are quite different, which may introduce large test fluctuations. In the latter case, the molecules to be tested are preferentially adsorbed or close to the surface of the SERS nanoprobe, and then the aggregating agent is added to promote the aggregation of the nanoprobe, which may cause the molecules to be tested to be buried inside the aggregate, thereby reducing the number of molecules to be tested that provide signals. At the same time, in both addition orders, the surface of the SERS probe will undergo secondary changes (aggregation first and then adsorption or adsorption first and then aggregation), which will introduce unreliable test results. Based on this, the sample addition order proposed by the present invention is: first mix the sample and the aggregating agent evenly, and then add the SERS probe.
[0039] (3) In order to reduce the influence of the sample matrix, a small amount of sample is generally added. However, when two solutions are mixed with each other, the interface that first contacts changes most dramatically, which may cause local inhomogeneity of the system. When mixed at a near volume ratio, the larger the interface that first contacts, the smaller the impact of introducing local inhomogeneity into the system. Based on this, the present invention proposes to add a near-volume pretreated sample to the SERS nanoprobe, so in step S2, the volume ratio of the added pretreated sample to the SERS probe is 1:3 to 3:1, so as to obtain a more uniform SERS nanoprobe aggregate test system.
[0040] (4) The sample and the SERS nanoprobe are usually mixed by vortex mixing. Vortex mixing uses the rotational motion generated by the agitator and the circulation effect inside the liquid to mix the different components in the liquid evenly. However, the effect of vortex mixing is not as good as the dispersion effect of nanoparticles by ultrasonic dispersion. The specific principle of ultrasonic dispersion is: using the high-intensity sound wave energy generated by ultrasonic oscillation to form local high-pressure and low-pressure areas in the liquid, thereby generating tiny bubbles and vortices; when the bubbles burst, high pressure is generated, thereby dispersing the particles. Ultrasonic waves can achieve uniform dispersion of particles in a relatively short time without causing thermal and chemical damage to the particles. In order to improve the uniformity of the system to be tested, the present invention proposes for the first time to add a pre-treated sample of a similar volume at the same time as the ultrasonic SERS nanoprobe. It is expected that under the action of ultrasonic dispersion, the rapid aggregation of SERS nanoprobes and the adsorption of the molecules to be tested can be more uniform, thereby obtaining reliable detection signals.
[0041] (5) On the basis of the uniformity of the SERS enhanced substrate, choosing the appropriate data collection and processing method can ensure that the real signal of the sample is accurately represented. In the colloidal SERS nanoprobe detection system, since the nanoparticles are in Brownian motion all the time, each detection space unit is constantly changing. Then the detection system can be regarded as an infinite population sample, and the number of sampling detections n of the detection space unit can be estimated according to Formula 1. Among them, the unknown population standard deviation σ is estimated according to the test method in Example 1. Specifically, the method in Example 1 is used to test 1 sample with MTX concentrations of 0.04, 0.2, 0.4, 2, 4, 10, and 35 μg / mL, and each sample is scanned 600 times, that is, 600 detection space units are detected. The standard deviation of 600 detection space units is used instead of the population standard deviation, and the minimum number of spectra collected is estimated according to Formula 1. If the acceptable sampling relative error is 10%, the number of spectra collected for each concentration sample is at least 73, 30, 10, 9, 10, and 10, respectively.
[0042]
[0043] n: sample size
[0044] σ: population standard deviation
[0045] Ε: Sampling error, which can be set as a percentage of the mean
[0046] Z α / 2 : Reliability coefficient, i.e. confidence level, when the confidence level is 95%, the value is 1.96
[0047] A further SERS spectrum acquisition scheme of the present invention is: a plurality of spectra are acquired for each sample using a scanning mode, and the specific number of acquisitions is estimated by formula 1.
[0048] Preferably, the further SERS spectrum acquisition scheme of the present invention is: for each sample, multiple spectra are acquired using a scanning mode, and the specific acquisition number is not less than n=6.747c -0.705 +8, where c is the concentration of the substance to be tested, and n is the minimum number of spectra collected to test samples near this concentration. The constant 8 represents the minimum number of samples collected by the detection system, which is determined by the inherent properties of the fluctuation of surface enhanced Raman spectroscopy data collection and is the overall statistical result of factors such as molecular Brownian motion, particle adsorption characteristics, and dark current of the spectral system.
[0049] Preferably, the further SERS spectrum acquisition scheme of the present invention is: in combination with the concentration range of the sample to be tested in the actual application scenario, the number of spectra required for the minimum concentration of the sample to be tested is estimated as the minimum acquisition number of the series of sample spectra to be tested. In addition to the detection of methotrexate, the present invention also verifies again that the optimization scheme has the effect of significantly improving repeatability by detecting voriconazole and verapamil hydrochloride. In addition, the present invention examines the short-term stability of the optimized detection system and proves that its detection is stable. BRIEF DESCRIPTION OF THE DRAWINGS
[0050] Figure 1 The original average spectra of the control MTX samples at 0, 0.2, and 10 μg / mL;
[0051] Figure 2 Example 1 sample average spectrum;
[0052] Figure 3 Example 1 standard curve;
[0053] Figure 4 Example 2 standard curve;
[0054] Figure 5 Example 3 standard curve;
[0055] Figure 6 VCZ SERS spectrum;
[0056] Figure 7 Example 5 standard curve;
[0057] Figure 8 VER SERS spectrum;
[0058] Fig. 9 Example 6 Standard curve. DETAILED DESCRIPTION
[0059] Comparison Example
[0060] Step 1. Preparation of sodium citrate silver nano-SERS probe:
[0061] 1) Add 110 mL of ultrapure water to a three-necked flask, place it in an oil bath, turn on magnetic stirring, and set the stirring speed to 800 rpm.
[0062] 2) Weigh 23 mg of AgNO3 in 40 mL of ultrapure water and vortex to mix. Add 40 mL of AgNO3 aqueous solution to a three-necked flask, mix well and protect from light.
[0063] 3) Turn on the heat and bring to a boil.
[0064] 4) Weigh 40 mg of sodium citrate solution in 4 mL of ultrapure water and vortex to mix. Add 2 mL of sodium citrate solution into the three-necked flask at a uniform rate within 5 minutes.
[0065] 5) After boiling for 1 hour, stop heating. Place the three-necked flask at room temperature away from light and continue stirring for 3 hours until it cools down.
[0066] 6) The prepared sodium citrate silver nano-SERS probe was stored at 2-8°C in the dark.
[0067] Step 2. Incubation of SERS probe with MTX sample:
[0068] After the SERS probe returns to room temperature, ultrasonically disperse it for 1 minute, take 90 μL of the probe into an incubation tube, add 10 μL of MTX sample, and vortex to mix evenly. Among them, the MTX sample is a series of solutions obtained by gradient dilution of 1 mg / mL MTX with 100 mM NaHCO3 aqueous solution (MTX concentration is 0, 0.2, 10 μg / mL). Step 3. SERS detection:
[0069] Take an appropriate amount of the mixed incubation sample and place it on the sample stage of the Raman spectrometer. Use 633nm wavelength laser excitation, integration time 1s, scan and collect spectra, and step length is 10μm. Each sample is tested 3 times. Step 4. Data processing and analysis:
[0070] After baseline correction of the original spectrum, the average spectrum of each test sample was obtained. The characteristic peak of MTX at 1360 cm in the average spectrum was calculated. -1 The peak area at is taken as the SERS signal.
[0071] Figure 1 The original average spectra obtained from the test of 0, 0.2, and 10 μg / mL MTX samples show that the 10 μg / mL MTX sample has a significant Raman signal, while the 0.2 μg / mL MTX sample has no visible difference from the sample without MTX. Table 1 is the calculation of the 1360 cm -1 The results of the peak area at , also showed that there was no signal difference between the 0.2 μg / mL MTX sample and the sample without MTX, that is, the 0.2 μg / mL MTX sample was undetectable.
[0072] Table 1 Comparative Example Sample 1360cm -1 Peak area
[0073]
[0074] Example 1
[0075] The control method failed to detect low-concentration methotrexate. Example 1 achieved low-concentration methotrexate detection by optimizing incubation (introducing agglomerating agents) and spectral acquisition modules. The specific scheme and conclusion are as follows:
[0076] Step 1. Preparation of sodium citrate silver nano SERS probe: Use the SERS probe prepared in the control example.
[0077] Step 2. Prepare the pretreatment solution:
[0078] Prepare an aqueous solution containing 135 mM NaCl, 3.5 mM KCl, 2.2 mM CaCl2, and 0.7 mM MgCl2.
[0079] Step 3. Incubate the SERS probe with the MTX sample: After the SERS probe returns to room temperature, ultrasonically disperse it for 1 minute, take 50 μL of the probe into an incubation tube, add 40 μL of pretreatment solution and 10 μL of MTX sample, and vortex to mix evenly. Among them, the MTX sample is a series of solutions obtained by gradient dilution of 1 mg / mL MTX with 100 mM NaHCO3 aqueous solution (MTX concentrations are 0.04, 0.2, 0.4, 2, 4, 10, 35 μg / mL). Repeat the incubation and detection 5 times for each sample.
[0080] Step 4. SERS detection: Take an appropriate amount of the mixed incubation sample and place it on the sample stage of the Raman spectrometer. Use 633nm wavelength laser excitation, integration time 1s, use scanning mode for spectrum acquisition, and step length of 10μm. According to n=6.747c -0.705 +8 (from ) It is estimated that the number of spectra required to be collected when the lowest concentration x = 0.04 μg / mL is 73. The number of spectra collected for the MTX series samples is 100 (>73).
[0081] Step 5. Data processing and analysis: After baseline correction of the original spectrum, the average spectrum of each test sample was obtained. The MTX characteristic peak 1360cm in the average spectrum was calculated. -1 The peak area at is taken as the SERS signal and a standard curve is drawn.
[0082] from Figure 2It can be seen that when MTX is detected by the method of Example 1, the spectra of MTX samples with a concentration of 0 to 35 μg / mL are significantly distinguished, and the detection performance is improved compared with the control example. Each MTX sample is tested 5 times, and the 1360 cm -1 The peak area mean Ave, standard deviation SD and coefficient of variation CV at 1360 cm -1 The peak area at is taken as the signal and a standard curve is drawn, such as Figure 3 As shown in the figure, the fitted standard curve has good correlation, R 2 is 0.99.
[0083] Table 2 Calibration statistics of Example 1
[0084]
[0085]
[0086] Example 2
[0087] The method of Example 1 can detect low concentrations of methotrexate, but its coefficient of variation CV is large. This Example 2 optimizes the incubation detection module based on Example 1 and significantly reduces the CV. The specific implementation method and conclusion are as follows:
[0088] Step 1. Preparation of sodium citrate silver nano SERS probe: Use the SERS probe prepared in the control example.
[0089] Step 2. Prepare pretreatment solution: prepare an aqueous solution containing 135 mM NaCl, 3.5 mM KCl, 2.2 mM CaCl2, and 0.7 mM MgCl2.
[0090] Step 3. Incubation of SERS probe and MTX sample: After the SERS probe returns to room temperature, ultrasonically disperse for 1 min, take 50 μL of the probe in an incubation tube and place it in an ultrasonic tank, turn on the ultrasound, and quickly add 50 μL of the MTX sample diluted with the pretreatment solution (MTX sample dilution: 20 μL of MTX sample is added to 80 μL of pretreatment solution and mixed evenly), continue ultrasonication for 10 s, and incubate at 20°C in the dark for 10 min. Repeat the incubation and detection for each sample 5 times.
[0091] Step 4. SERS detection: ultrasonically treat the incubated sample for 10 seconds, take an appropriate amount of sample and place it on the sample stage of the Raman spectrometer. Use 633nm wavelength laser excitation, integration time 1 second, scan 100 frames, and step length of 10μm.
[0092] Step 5. Data processing and analysis: After baseline correction of the original spectrum, the average spectrum of each test sample was obtained. The MTX characteristic peak 1360cm in the average spectrum was calculated. -1The peak area at is taken as the SERS signal and a standard curve is drawn.
[0093] Table 3 shows the MTX samples of various concentrations in Example 2 at 1360 cm -1 The peak area mean, SD and CV at the same time. Compared with the calibration statistical data of Example 1, the CV range of the signal in Example 2 is 3.7% to 14.8%, which is significantly reduced compared with the CV range of 14.6% to 24.7% in Example 1. The standard curve of Example 2 is drawn as follows: Figure 4 As shown, the standard curve has good correlation, R 2 is 0.99.
[0094] Table 3 Calibration statistics of Example 2
[0095]
[0096]
[0097] Example 3
[0098] Based on Example 2, the effect of the concentration of the pretreatment solution on the CV of the detection system was verified. It is shown that the method of reducing CV in Example 2 is still effective in a wide concentration range. The specific scheme and conclusion are as follows:
[0099] Step 1. Preparation of sodium citrate silver nano SERS probe: Use the SERS probe prepared in the control example.
[0100] Step 2. Prepare pretreatment solution: prepare an aqueous solution containing 145 mM NaCl, 5 mM KCl, 2.6 mM CaCl2, and 1 mM MgCl2.
[0101] Steps 3 to 5 are consistent with steps 3 to 5 in Example 2.
[0102] The calibration data of Example 3 are summarized in Table 4, where the signal mean and CV are similar to those of Example 2. The standard curve fitting correlation is good, R 2 can reach 0.99, the standard curve is as follows Figure 5 shown.
[0103] The sample concentrations and coefficients of variation were calculated using the fitted standard curve equations for Example 1, Example 2, and Example 3, respectively. The results are shown in Table 5. The CV mean values of Example 2 and Example 3 are significantly lower than the CV value of Example 1 (generally lowered by >10%). This indicates that the optimized detection can improve test repeatability.
[0104] Table 4 Calibration statistics of Example 3
[0105]
[0106]
[0107] Table 5 CV statistics of sample concentrations in Example 1 to Example 3
[0108]
[0109] Example 4
[0110] Verify the stability of MTX detected by the system in Example 2. The scheme and conclusion are as follows:
[0111] (1) MTX sample aliquoting and storage. Prepare 100 μg / mL MTX sample solution, aliquot into 0.5 mL / centrifuge tube, seal with sealing film, and store in a refrigerator <-20℃.
[0112] (2) Stability monitoring. On the 3rd, 7th and 14th days after calibration, the 10 and 0.2 μg / mL MTX samples were tested according to the steps of Example 2, and each sample was tested 3 times. On the day of testing, the 100 μg / mL MTX sample solution was restored to room temperature in advance and gradiently diluted to 10 and 0.2 μg / mL MTX sample solutions using 100 mM NaHCO3 aqueous solution.
[0113] The detection concentrations of 0.2 μg / mL and 10 μg / mL MTX samples on days 3, 7, and 14 were calculated by back-calculating the standard curve equation of Example 2 and are summarized in Table 6. Within 14 days, the relative deviation RD of the mean detection concentration was less than 10%, and the overall CV was less than 20%, indicating that the detection system had good short-term stability.
[0114] Table 6 MTX detection stability
[0115]
[0116] Example 5
[0117] Voriconazole (VCZ) is a second-generation triazole antifungal drug with broad-spectrum antifungal activity. Its infection treatment effect and hepatotoxicity are significantly correlated with blood drug concentrations. In addition, VCZ metabolism has large individual differences. Therefore, it is necessary to monitor the drug concentration of VCZ to optimize the dosing regimen.
[0118] This example demonstrates that the optimized SERS detection scheme can also be applied to VCZ detection. The specific scheme and conclusion are as follows:
[0119] Step 1. Preparation of sodium citrate silver nano SERS probe: same as Example 2.
[0120] Step 2. Prepare the pretreatment solution: same as in Example 2. The number of spectrum collected by the sample meets the rule of Example 1.
[0121] Step 3. Prepare VCZ samples. Use ultrapure water to dilute the 2 mg / mL VCZ ethanol solution 20 times to 100 μg / mL. Then use ultrapure water to dilute the 100 μg / mL VCZ sample in a gradient manner, and the concentrations after dilution are 0.05, 0.5, 1, 5, and 10 μg / mL.
[0122] Step 4. Incubation of SERS probe and VCZ sample: same as Example 2.
[0123] Step 5. SERS detection: same as Example 2.
[0124] Step 6. Data processing and analysis: After baseline correction of the original spectrum, the average spectrum of each test sample was obtained. The characteristic peak of voriconazole at 740 cm in the average spectrum was calculated. -1 The peak area at is taken as the SERS signal ( Figure 6 is the SERS spectrum of VCZ sample), and a standard curve is drawn.
[0125] The calibration data of Example 5 are summarized in Table 7. In the concentration range of 0.05 to 10 μg / mL, the signal CV is less than 15%. The standard curve fitting correlation is good, R 2 can reach 0.985, such as Figure 7 The sample concentration was calculated using the fitting standard curve equation and its coefficient of variation was calculated. It was found that the CV of the sample test back-calculated concentration was small, all less than 20%, as shown in Table 8. The optimization scheme of the present invention is also applicable to VCZ detection.
[0126] Table 7 Calibration statistics of Example 5
[0127]
[0128] Table 8 CV statistics of sample concentration in Example 5
[0129]
[0130] Example 6
[0131] Verapamil hydrochloride (VER) is a calcium channel blocker, commonly used to treat cardiovascular diseases such as hypertension and angina pectoris. It blocks calcium ion channels on the cell membrane, reduces the strength of vasoconstriction and cardiac contraction, thereby lowering blood pressure and relieving angina pectoris symptoms. Overdose of Verapamil hydrochloride can cause serious complications such as severe hypotension and bradycardia, so it is necessary to detect the drug concentration. This example verifies that the optimized SERS detection scheme can be applied to the detection of VER, and the specific scheme is as follows:
[0132] Step 1. Preparation of sodium citrate silver nano SERS probe: same as Example 2.
[0133] Step 2. Prepare pretreatment solution: same as Example 2.
[0134] Step 3. Prepare VER samples: Use ultrapure water to gradiently dilute 1 mg / mL VER aqueous solution to a concentration of 0.05, 0.5, 1, 5, and 10 μg / mL after dilution.
[0135] Step 4. Incubation of SERS probe and VER sample: same as Example 2.
[0136] Step 5. SERS detection: Same as Example 2. The number of sample acquisition spectra meets the rule of Example 1.
[0137] Step 6. Data processing and analysis: After baseline correction of the original spectrum, the average spectrum of each test sample is obtained. The peak area of the VER characteristic peak at 2250 cm-1 in the average spectrum is calculated as the SERS signal ( Figure 8 is the SERS spectrum of high concentration VER), and a standard curve is drawn.
[0138] The calibration data of Example 6 are summarized in Table 9. In the concentration range of 0.001 to 5 μg / mL, the signal CV is less than 15%. The standard curve fitting correlation is good, R 2 can reach 0.99, such as Fig. 9 The sample concentration was calculated using the fitted standard curve equation and its coefficient of variation was calculated. It was found that the CV of the sample test back-calculated concentration was small, basically less than 20%, as shown in Table 10. The optimization scheme of the present invention is also applicable to VER detection.
[0139] Table 9 Calibration statistics of Example 6
[0140]
[0141] Table 10 CV statistics of sample concentrations in Example 6
[0142]
[0143] Conclusion: This paper develops a method for detecting multiple drugs based on surface enhanced Raman spectroscopy. This method can achieve high-sensitivity, high-repeatability and stable detection of multiple drugs through sample pretreatment, incubation, SERS detection, data processing and other steps.
Claims
1. A method for drug concentration detection based on surface enhanced Raman spectroscopy, characterized in that: The following steps are involved: Step 1: Mixing a sample pretreatment solution with a sample in a certain proportion to obtain a pretreated sample, wherein the sample pretreatment solution is one or more of sodium salt, potassium salt, calcium salt, and magnesium salt; and the sample is methotrexate, voriconazole, or verapamil hydrochloride; Step 2: While the SERS probe is being sonicated, the pre-treated sample is quickly added for mixed incubation; the volume ratio of the added pre-treated sample to the SERS probe is 1:3 to 3:1; Step 3: Perform SERS detection on the incubated samples after ultrasonication to obtain raw spectral data; wherein, the SERS spectra of the incubated samples are collected using a scanning mode, and multiple spectra are collected for each sample. The specific number of spectra collected is estimated by the following formula: , where σ is the standard deviation, Ε is the acceptable sampling error, and Z α / 2 is the reliability coefficient; based on the concentration range of the sample to be tested in the actual application scenario, the number of spectra required to be collected for the lowest concentration of the sample to be tested is estimated as the minimum number of spectra collected for the sample to be tested; Step 4: Select the characteristic peak of the target detection object, calculate its peak area in the average spectrum as the signal, draw a standard curve, and realize quantitative detection.
2. The method for drug concentration detection based on surface enhanced Raman spectroscopy according to claim 1, characterized in that: The concentration of the sample pretreatment solution ranges from 0.01 to 150 mM.
3. The method for drug concentration detection based on surface enhanced Raman spectroscopy according to claim 1, characterized in that: The SERS probe comprises any one of silver, gold and platinum, and its particle size is 20 to 200 nm.
4. The method for drug concentration detection based on surface enhanced Raman spectroscopy according to claim 1, characterized in that: The ultrasound is water bath ultrasound, and the ultrasound power is 200-1000 Hz.
5. The method for drug concentration detection based on surface enhanced Raman spectroscopy according to claim 1, characterized in that: When the confidence level is 95% and the acceptable relative sampling error is 10%, Z α / 2 The value is 1.96, and the specific number of spectra collected is not less than , where x is the concentration of the substance to be tested, and y is the minimum number of spectra collected to test samples near this concentration; The characteristic peak area is calculated as the peak center wave number ±5 to 30 cm after removing the baseline. -1 The integrated area within the range.
6. The method for drug concentration detection based on surface enhanced Raman spectroscopy according to any one of claims 1 to 4, characterized in that: The steps of SERS probe detection for MTX samples are as follows: Prepare pretreatment solution: an aqueous solution containing 135-145 mM NaCl, 3.5-5 mM KCl, 2.2-2.6 mM CaCl2, and 0.7-1 mM MgCl2; Sample pretreatment: Mix 10 μL of methotrexate sample with 90 μL of pretreatment solution for subsequent testing; Place the incubation tube containing the SERS nanoprobe in an ultrasonic bath, turn on the ultrasound, and quickly add the pretreated sample at a volume ratio of 1:3 to 3:
1. Continue ultrasound for 10 s and incubate at 20°C in the dark for 10 min. Detection: Ultrasonicate the incubated samples for 10 seconds and take an appropriate amount of sample for detection.
7. The method for drug concentration detection based on surface enhanced Raman spectroscopy according to any one of claims 1 to 4, characterized in that: The preparation process of SERS probe is as follows: Add 110 mL of ultrapure water to a three-necked flask, place it in an oil bath, turn on magnetic stirring, and set the stirring speed to 800 rpm; Weigh 23 mg of AgNO3 in 40 mL of ultrapure water and vortex to mix; add 40 mL of AgNO3 aqueous solution into a three-necked flask, mix well, and protect from light; Turn on heat and bring to boil; Weigh 40 mg of sodium citrate solution in 4 mL of ultrapure water and vortex to mix; add 2 mL of sodium citrate solution into the three-necked flask at a uniform rate within 5 minutes; After boiling for 1 hour, stop heating; place the three-necked flask at room temperature away from light, and continue stirring for 3 hours until it cools down; The prepared sodium citrate silver nano-SERS probe was stored at 2-8°C in the dark.
